The EMA does not approve/grant marketing authorisation. The European Commission does.
The EMA is an agency that evaluates drugs for the European Commission. They do this through scientific committees. The CHMP is the scientific committee that does scientific research for drugs for human use. The CHMP opinion is the EMA opinion. That is given to the EU Commission who decides whether to approve marketing authorisation.
My bad. I thought that the EMA was the issuing Directorate for the EUC MA, hence "EMA decision" my point was that pulsing the EMA/CHMP site for news was futile and that at this time of year, expecting timely updates to the various EUC websites was rather problematic.